Elanco
Greenfield, Indianaelanco.com
Overview
Elanco is a global animal health company that develops, manufactures, and markets products and services to prevent and treat diseases in farm animals and pets. The company was formerly a subsidiary of Eli Lilly and Company before becoming fully independent in 2019. While its primary role is an operating company, Elanco also engages in strategic investments, such as co-founding BiomEdit by contributing intellectual property and assets in exchange for equity.
Portfolio Companies
3
Website
elanco.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Athian | Nov 2023 | Series A | Co-investor |
| Resilient Biotics | Jan 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.